Tragic Death of Teen Highlights Concerns Over Birth Control Safety
The family of Aine Rose Hurst, a 19-year-old who tragically passed away from a blood clot attributed to a prescribed contraceptive pill, is calling for increased awareness about the potential risks associated with hormonal contraceptives. Aine, who died in March of last year, had been recently reinstated on the contraceptive Femodette after her blood pressure normalised.
Family’s Plea for Awareness
Aine’s mother, Kerry Hurst, and her aunt, Dawn Kidd, spoke candidly about the need for better education regarding the side effects of birth control alternatives. In an interview with Sky News, they emphasized that a lack of accessible information could prevent similar tragedies in the future.
A report from the Bolton GP Federation revealed that both the coroner and the federation’s internal review concluded that Aine was prescribed medication appropriately, adhering to established NHS guidelines. However, the family feels that proactive measures to inform young women about the risks of hormonal contraceptives are necessary.
The Circumstances of Aine’s Death
In the months leading up to her death, Aine had been taken off Femodette due to elevated blood pressure but was eventually cleared to resume taking the contraceptive. Aine experienced severe headaches for several days before her collapse, prompting her mother to seek medical attention after her daughter’s condition deteriorated.
Initially, Aine’s symptoms were met with telephonic consultation advice from medical professionals. However, during the call, Aine lost consciousness, leading to an emergency ambulance dispatch. Despite hospital efforts, doctors decided not to operate on the blood clot due to its size and location, ultimately resulting in Aine’s passing shortly after life support was withdrawn.
Calls for Reform and Better Education
In light of Aine’s untimely death, both Mrs. Hurst and Ms. Kidd insist that there should be more straightforward labelling and information regarding the side effects of contraceptive pills. Ms. Kidd remarked on the lengthy 102-page leaflet included with Aine’s contraceptive, pointing out that such extensive information often goes unread, particularly by younger women.
Mrs. Hurst added that medications should not be accessible without adequate knowledge about their potential effects, urging for reform in how contraceptives are marketed and prescribed.
Background
The risks associated with combined hormonal contraception, including blood clots, have been a topic of medical discourse for years. According to NHS guidance, these risks are statistically low, impacting roughly one in every 1,000 users. Nonetheless, Aine’s case underscores the importance of patient education and informed consent in the healthcare system.
As family members navigate their grief, they are determined to advocate for changes that could potentially spare other families from similar heartache in the future.
Source: Original Article
